Resource Center
Resource Center
We are delighted to announce the joint launch of a partnership to speed up development and introduction of optimized pediatric formulations of dolutegravir for children living with HIV in resource-limited settings. The new initiative includes an incentive program and is a key feature of Unitaid’s US$34 million Optimal Antiretroviral (ARV) grant to CHAI. The optimal...
Read moreIntroducing the second edition of CHAI’s HIV Mid-Year Market Memo, an informational brief that covers the latest trends in the HIV space in low- and middle-income countries (LMICs) since the publication of CHAI’s annual ARV Market Report in September 2017. See the HIV Mid-Year Market Memo here. See the 2017 ARV Market Report here.
Read moreIn 2013, Uganda introduced an HIV test-and-treat policy into its national healthcare guidelines, as recommended by the World Health Organization. This provided all people under the age of 15 with antiretroviral therapy (ART) immediately after their HIV positive status was confirmed. With the new policy, the country saw a nearly 50 percent increase in the...
Read moreCHAI supports national governments to expand high-quality care and treatment to people living with HIV/AIDS. CHAI negotiates reduced prices for antiretroviral (ARVs) on behalf of members of its procurement consortium. See the 2017 CHAI ARV Reference Price List here.
Read moreI joined CHAI as a volunteer in February 2003. I had just graduated with a Master’s degree in economics from the London School of Economics and returned home to Kenya. While on the job hunt, a friend of mine volunteering with CHAI from McKinsey and Company asked if I would be interested in joining their...
Read moreThis World AIDS Day, we celebrate the tremendous progress that has been made in response to the HIV/AIDS epidemic, with more than 20 million people living with HIV accessing life-saving antiretroviral treatment (ART) as of today. The incredible scale up of ART in developing countries, with affordable generic drugs widely available and the majority of...
Read moreI grew up privileged. Access to clean water, food, health care, and education was never an issue during my childhood in California. While we were never wealthy from an American perspective, we always had enough to meet our basic needs. This privilege is something most of the world’s population lacks, and I am mindful that...
Read moreIt was the spring of 1998, while working as a clinician in Lesotho, that I first realized the terrible impact that HIV would have on my country. Patients were growing sicker by the day, and at times I thought I might not even have any more patients to care for within a few years. We...
Read moreYears of experience show that licensing is highly effective for ensuring that many more people in developing countries can access life-saving HIV medicines. CHAI and Access to Medicine Foundation have published a paper outlining best practice licensing models that originator companies should employ to enable widespread access to their drugs. It also explores how these...
Read moreThis webinar, the second in a two-part series, highlights tools and resources in CHAI’s HIV New Product Introduction Toolkit. The toolkit provides ministries of health and implementing partners with the tools necessary to evaluate the adoption and introduction of new HIV products in their local context. This webinar highlighted two consumption monitoring tools, including: 1)...
Read more